Kazia Therapeutics Stock Australian S.E.
Equities
KZA
AU000000KZA9
Biotechnology & Medical Research
Sales 2022 | 10K 6.58K 9.05K | Sales 2023 | 555 365.3 502.36 | Capitalization | 39.72M 26.14M 35.95M |
---|---|---|---|---|---|
Net income 2022 | -24M -15.8M -21.72M | Net income 2023 | -20M -13.16M -18.1M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.85M 6.66M | Net cash position 2023 | 3.44M 2.27M 3.12M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Kazia Therapeutics
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |